Just received this from Neuromod:
[News] Lenire's TENT A1 trial results published by STM
Hi,
In 2016 we set out on the largest and longest followed-up clinical trial of a medical device for tinnitus sufferers. It's been quite a journey.
Over 3 years our TENT A1 trial investigated if Lenire's non-invasive bimodal neuromodulation treatment (Lenire uses wireless headphones which deliver specific audio tones and background noise while our Tonguetip® delivers mild electrical stimulation to your tongue) could reduce the severity of tinnitus symptoms.
326 participants took part and we measured their symptoms up to 12 months post treatment.
Fast forward to today and we are proud to say the results of our trial show that Lenire is a clinical success at reducing the symptoms of tinnitus.
What were the results?
- 86.2% of treatment compliant participants reported an improvement in tinnitus symptom severity after 12 weeks of treatment;
- 80.1% of treatment compliant participants experienced continued improvement in tinnitus symptom severity when evaluated 12-months post-treatment;
- 77.8% of participants said they'd recommend Lenire to others.
See the results for yourself, here's a list of our resources about the results of the study:
Why are these results significant?
For tinnitus sufferers without an effective treatment option available to them there's now a clinically proven alternative providing sustained improvement of symptoms.
Our results were published in last week's edition of the highly regarded medical journal
Science Translational Medicine in a paper titled: 'Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study'.
The peer-reviewed publication in a top scientific and clinical journal supports the credibility and acceptance of Lenire's results by the medical and research communities for meeting the needs of tinnitus sufferers.
Interested in starting your journey with Lenire? Find a clinic today.